Moderna (MRNA) fell 6.5% on 5 Nov 2026. The stock closed at $241.46, against $258.38 the session before.
That puts the company's market value at about $96.4B. The 52-week range is $22.28 to $260.67, so the stock now sits 7.4% below the top of it.
Over the past 52 weeks the shares have moved +962.0%.
Figures from Yahoo Finance at the time of writing. Not investment advice.